OBJECTIVES: Data on the acquisition of human papillomavirus (HPV) infection in men are limited, especially from developing regions including Africa. The objective of this study was to characterise and determine the risk factors of HPV acquisition among a cohort of uncircumcised men participating in a randomised controlled trial (RCT) of male circumcision in Kisumu, Kenya. METHODS:Penile exfoliated cell specimens were collected at baseline, 6- and 12-month follow-up visits from the glans/coronal sulcus and shaft of men enrolled in the control arm of the RCT between 2002 and 2005. All participants were HIV seronegative, aged 17-24 years at baseline and remained uncircumcised over follow-up. Specimens were tested with GP5+/6+ PCR to detect 44 HPV types. Parametric frailty models were used to assess risk factors of HPV incidence. RESULTS:The median age of 966 participants was 20 years. The median follow-up time was 12.1 months. The incidence rate (IR) of any HPV infection was 49.3/1000 person-months with HPV16 having the highest IR (10.9/1000 person-months). The strongest risk factors for overall HPV incidence were bathing less frequently than daily (adjusted HR=2.6; 95% CI 1.0 to 6.5) and having ≥ 2 female sexual partners in the past year (adjusted HR=1.6; 95% CI 1.2 to 2.1). CONCLUSIONS: HPV IRs were notably high in this cohort of high-risk, uncircumcised men from Kisumu, Kenya, with the number of sexual partners and bathing frequency being the strongest risk factors.
RCT Entities:
OBJECTIVES: Data on the acquisition of humanpapillomavirus (HPV) infection in men are limited, especially from developing regions including Africa. The objective of this study was to characterise and determine the risk factors of HPV acquisition among a cohort of uncircumcised men participating in a randomised controlled trial (RCT) of male circumcision in Kisumu, Kenya. METHODS: Penile exfoliated cell specimens were collected at baseline, 6- and 12-month follow-up visits from the glans/coronal sulcus and shaft of men enrolled in the control arm of the RCT between 2002 and 2005. All participants were HIV seronegative, aged 17-24 years at baseline and remained uncircumcised over follow-up. Specimens were tested with GP5+/6+ PCR to detect 44 HPV types. Parametric frailty models were used to assess risk factors of HPV incidence. RESULTS: The median age of 966 participants was 20 years. The median follow-up time was 12.1 months. The incidence rate (IR) of any HPV infection was 49.3/1000 person-months with HPV16 having the highest IR (10.9/1000 person-months). The strongest risk factors for overall HPV incidence were bathing less frequently than daily (adjusted HR=2.6; 95% CI 1.0 to 6.5) and having ≥ 2 female sexual partners in the past year (adjusted HR=1.6; 95% CI 1.2 to 2.1). CONCLUSIONS:HPV IRs were notably high in this cohort of high-risk, uncircumcised men from Kisumu, Kenya, with the number of sexual partners and bathing frequency being the strongest risk factors.
Authors: Jennifer S Smith; Lisa Lindsay; Brooke Hoots; Jessica Keys; Silvia Franceschi; Rachel Winer; Gary M Clifford Journal: Int J Cancer Date: 2007-08-01 Impact factor: 7.396
Authors: Robert C Bailey; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; John N Krieger; Carolyn F M Williams; Richard T Campbell; Jeckoniah O Ndinya-Achola Journal: Lancet Date: 2007-02-24 Impact factor: 79.321
Authors: Jennifer S Smith; Danielle M Backes; Michael G Hudgens; Robert C Bailey; Giovanni Veronesi; Martijn Bogaarts; Kawango Agot; J O Ndinya-Achola; Ian Maclean; Walter Agingu; Chris J L M Meijer; Stephen Moses; Peter J F Snijders Journal: Int J Cancer Date: 2010-01-15 Impact factor: 7.396
Authors: Beibei Lu; Yougui Wu; Carrie M Nielson; Roberto Flores; Martha Abrahamsen; Mary Papenfuss; Robin B Harris; Anna R Giuliano Journal: J Infect Dis Date: 2009-02-01 Impact factor: 5.226
Authors: Anna R Giuliano; Guillermo Tortolero-Luna; Elena Ferrer; Ann N Burchell; Silvia de Sanjose; Susanne Kruger Kjaer; Nubia Muñoz; Mark Schiffman; F Xavier Bosch Journal: Vaccine Date: 2008-08-19 Impact factor: 3.641
Authors: Anna R Giuliano; Beibei Lu; Carrie M Nielson; Roberto Flores; Mary R Papenfuss; Ji-Hyun Lee; Martha Abrahamsen; Robin B Harris Journal: J Infect Dis Date: 2008-09-15 Impact factor: 5.226
Authors: Mahboobeh Safaeian; Mohammad Kiddugavu; Patti E Gravitt; Stephen J Gange; Joseph Ssekasanvu; Dan Murokora; Marc Sklar; David Serwadda; Maria J Wawer; Keerti V Shah; Ron Gray Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-06 Impact factor: 4.254
Authors: Jennifer S Smith; Danielle M Backes; Brooke E Hoots; Robert J Kurman; Jeanne M Pimenta Journal: Obstet Gynecol Date: 2009-04 Impact factor: 7.661
Authors: Santiago Neme; Elizabeth Wahome; Grace Mwashigadi; Alexander N Thiong'o; Joanne D Stekler; Anna Wald; Eduard J Sanders; Susan M Graham Journal: Open Forum Infect Dis Date: 2015-05-12 Impact factor: 3.835
Authors: Roy Tapera; Eric Manyala; Patience Erick; Titus M Maswabi; Tshephang Tumoyagae; Baemedi Letsholo; Bontle Mbongwe Journal: Asian Pac J Cancer Prev Date: 2017-09-27
Authors: Admire Chikandiwa; Lucy Chimoyi; Pedro T Pisa; Matthew F Chersich; Etienne E Muller; Pamela Michelow; Philippe Mayaud; Sinead Delany-Moretlwe Journal: BMC Public Health Date: 2017-07-04 Impact factor: 3.295
Authors: Isabel Heidegger; Renate Pichler; Barbara Müller; Helmut Klocker; David Oswald; Bernhard Haid; Bettina Zelger; Wolfgang Horninger; Josef Oswald Journal: World J Urol Date: 2013-10-22 Impact factor: 4.226
Authors: Carmina Vera-Uehara; Miguel Angel Sánchez-Alemán; Felipe Javier Uribe-Salas; José Ramos-Castañeda; Ma Leónidez Olamendi-Portugal; Carlos Jesús Conde-Glez Journal: Braz J Infect Dis Date: 2013-09-19 Impact factor: 3.257